Pharma's Almanac

Mobile Navigation

Subscribe for the Newsletter

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

OBI Pharma

Sort By

1 / 1

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2025 PHARMA’S ALMANAC. All rights reserved.

1 / 1

OBI Pharma

Orphan Drug Designation

OBI Pharma Granted FDA Orphan Drug Designation for OBI-3424 for the Treatment of Acute Lymphoblastic Leukemia (ALL)

OBI Pharma

PR-M09-18-NI-082Sep 26, 2018